Health Canada has authorized Moderna to conduct a Phase 1 clinical trial for an mRNA vaccine targeting the Bundibugyo form of the Ebola virus, which is causing a large outbreak in eastern Congo with over 3,800 cases and 1,700 deaths. The trial will be conducted at three sites in Canada and aims to enroll around 80 participants. Health officials caution that even if the vaccine is successful, it may not be available to tackle the current outbreak for more than a year. This would make Canada the second country after the UK to launch a clinical trial for a Bundibugyo vaccine candidate.
Written by the local model on 2026-08-21,
using this article's own text rather than the other coverage of the
same event (that is the story summary below).
Why this leaning score
The article presents a neutral tone, but uses phrases like 'outpaces efforts to contain' and 'struggling to get the fast-spreading outbreak under control', which have slightly negative connotations towards the government's handling of the situation, leaning very slightly rightward.
Written under an earlier scoring contract, which gave a paragraph
rather than checkable quotes. Re-analysing this article replaces it.
Leaning score +0.10 for article 413 · logged 2026-08-05
Health Canada authorizes mRNA vaccine trial for Ebola virus causing huge outbreak in Congo
More than 3,800 cases have been recorded in eastern Congo, with some 1,700 deaths, according to latest figures
Health Canada has given Moderna the green light to launch a clinical trial for a vaccine targeting the Bundibugyo form of the Ebola virus — which continues to surge throughout the Democratic Republic of the Congo — as experts caution that the outbreak continues to outpace efforts to contain it.
uncertain
outbreak → authorize → it
Federal officials announced the recent authorization of Moderna’s mRNA shot on Tuesday, making Canada just the second country to launch a Phase 1 clinical trial for a Bundibugyo vaccine candidate after the U.K.
This form of the virus was long considered rare and has no approved vaccines or treatments, thwarting efforts to clamp down on what is already the second-deadliest Ebola outbreak on record.
asserted
what → announce → record
More than 1,700 known deaths and 3,800 infections have been recorded since mid-May as health-care teams in remote, conflict-filled areas of Congo are struggling to get the fast-spreading outbreak under control.
uncertain
outbreak → know → control
Moderna's trial is being conducted at three sites in Canada — Halifax and Truro in Nova Scotia, and in Toronto — and is expected to enroll roughly 80 participants.
asserted
trial → conduct → participants
The vaccine uses the same mRNA technology that was deployed for the first time during the COVID-19 pandemic.
80 participants expected
In a statement on Tuesday, Health Canada said the clinical trial will assess its vaccine’s safety, determine the right dosing and identify any side-effects in trial participants.
asserted
trial → use → participants
"Following this, Moderna would be required to conduct additional clinical trial phases before it could seek approval from Health Canada for the vaccine," it said.
uncertain
it → follow → vaccine
"Any final submission would need to meet Health Canada’s stringent safety, efficacy and quality standards before the vaccine could be allowed on the Canadian market."
uncertain
vaccine → need → market
As Ebola cases in Congo near 3,000, more health workers go on strike
Canada to temporarily bar entry by foreign nationals recently in Congo due to Ebola risk
asserted
Canada → near → risk
As part of an agreement with the Coalition for Epidemic Preparedness Innovations (CEPI), a global partnership working to accelerate the development of vaccines, Moderna has agreed to make a minimum of 500,000 doses available to low- and middle-income countries, if the shot is licensed, the company said in a statement.
asserted
company → work → statement
Moderna’s executive director of global health security and partnerships, Hamilton Bennett, told CBC News that the company hopes to begin analyzing Phase 1 trial results this fall, with the goal of conducting additional trials in impacted communities in Africa after that.
asserted
company → tell → that
Toronto-based infectious disease specialist Dr. Isaac Bogoch cautioned that any vaccine candidates — such as those in both Canada and the U.K. — could take more than a year to properly study, and may not pan out in time to tackle the current Ebola crisis.
uncertain
candidates → base → crisis
"We know that not all of them are going to work," he said.
asserted
he → know → them
"And it's important to have several different products being tested simultaneously because, ultimately, we're going to need this vaccine.
asserted
we → have → vaccine
The hope is that something's ready soon enough for this outbreak, but more realistic is that we have something in our back pocket for future outbreaks."
asserted
we → have → outbreaks
- Audio
Winnipeg researchers have found a new way to track the virus that causes Ebola
- Video
B.C. nurse helps families in Ebola-stricken Congo bury loved-ones with dignity
Bogoch, who has worked in Africa during previous outbreaks, says there is also potential for existing Ebola vaccines — those targeting the Zaire form of the virus — to be used in the current outbreak, as some research suggests they may show some benefit against Bundibugyo as well.
"
uncertain
they → find → Bundibugyo
So if that truly has some cross-protection … it would be far easier to implement because you've got a production pipeline, you've got safety data, and it's already been rolled out in in prior outbreaks," he said.
asserted
he → have → outbreaks
Initially confined to the Mongbwalu health zone in Congo's Ituri province, the current outbreak has expanded to five provinces over the last two months, and is now the largest Ebola outbreak ever reported in Congo, according to the World Health Organization (WHO), which deemed the situation a Public Health Emergency of International Concern back in May.
Neighbouring Uganda has also recorded 20 confirmed Ebola cases and two deaths this year, linked to the situation in Congo, and while the country declared an end to its outbreak on July 28, the WHO said it remains at risk of additional imported Bundibugyo cases.
uncertain
it → confine → cases
"The continued increase in cases, expanding geographic spread, and persistently high mortality underscore the rapidly evolving nature of this public health emergency," the WHO said in its latest update.
- Video
asserted
WHO → expand → update
'No need for panic' on Ebola case in France, WHO chief says
German hospital treats U.S. Ebola patient infected in Congo
Bogoch stressed that health-care workers on the ground have extensive experience tackling Ebola outbreaks over time through infection prevention and control efforts and community outreach, but given the distinct challenges facing teams in Congo right now, it won't happen overnight.
asserted
it → say → Congo
It took two years to stamp out a 2018 Ebola outbreak in Congo, he explained, "and that was one where a vaccine was available.
asserted
vaccine → take → Congo
"Sadly, this this is a bit of a trickier one," Bogoch said.
asserted
Bogoch → say → one
